Symposium Faculty will include: Bertha Madras, PhD, Harvard Medical School; Xue Han, PhD, Boston University; John Gabrieli, PhD, McGovern Institute for Brain Research, MIT; Miles Cunningham, MD, PhD, Harvard Medical School; and, T (Teo) Forcht Dagi, MD, DMedSc, Broadview Ventures.
‘This symposium will spotlight not only seminal advances in basic and applied science but also what they mean for entrepreneurs, medical product developers, healthcare providers, and patients,’ said Bertha Madras, PhD, Professor of Psychobiology, Harvard Medical School.

Click here to register for this symposium.

‘At this symposium, attendees will gain an up-to-date and broad perspective about where the treatment of neurological disease is headed, uncover possible new business opportunities, and meet some of the major players making this happen in the Greater Boston area,’ said Richard O’Brien, President of MDGBoston.

‘Advances in brain research are generating significant entrepreneurial opportunities,’ added Paul Hartung, President and CEO of Cognoptix, and a Director of ggag